Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery

Phytochemicals are plant-derived bioactive compounds, which have been widely used for therapeutic purposes. Due to the poor water-solubility, low bioavailability and non-specific targeting characteristic, diverse classes of nanocarriers are utilized for encapsulation and delivery of bio-effective ag...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chaoxiang Chen, Jialin Wang, Mengdi Sun, Jian Li, Hui-Min David Wang
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://doaj.org/article/578434f27eb14ee59a138eb6fea5d128
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:578434f27eb14ee59a138eb6fea5d128
record_format dspace
spelling oai:doaj.org-article:578434f27eb14ee59a138eb6fea5d1282021-11-14T04:30:33ZToward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery0753-332210.1016/j.biopha.2021.112416https://doaj.org/article/578434f27eb14ee59a138eb6fea5d1282022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0753332221012026https://doaj.org/toc/0753-3322Phytochemicals are plant-derived bioactive compounds, which have been widely used for therapeutic purposes. Due to the poor water-solubility, low bioavailability and non-specific targeting characteristic, diverse classes of nanocarriers are utilized for encapsulation and delivery of bio-effective agents. Cell-derived nanovesicles (CDNs), known for exosomes or extracellular vesicles (EVs), are biological nanoparticles with multiple functions. Compared to the artificial counterpart, CDNs hold great potential in drug delivery given the higher stability, superior biocompatibility and the lager capability of encapsulating bioactive molecules. Here, we provide a bench-to-bedside review of CDNs-based nanoplatform, including the bio-origin, preparation, characterization and functionalization. Beyond that, the focus is laid on the therapeutic effect of CDNs-mediated drug delivery for natural products. The state-of-art development as well as some pre-clinical applications of using CDNs for disease treatment is also summarized. It is highly expected that the continuing development of CDNs-based delivery systems will further promote the clinical utilization and translation of phyto-nanomedicines.Chaoxiang ChenJialin WangMengdi SunJian LiHui-Min David WangElsevierarticleCell-derived nanovesicles (CDNs)Extracellular vesicles (EVs)Natural productsNanoparticlesDeliveryTherapeutics. PharmacologyRM1-950ENBiomedicine & Pharmacotherapy, Vol 145, Iss , Pp 112416- (2022)
institution DOAJ
collection DOAJ
language EN
topic Cell-derived nanovesicles (CDNs)
Extracellular vesicles (EVs)
Natural products
Nanoparticles
Delivery
Therapeutics. Pharmacology
RM1-950
spellingShingle Cell-derived nanovesicles (CDNs)
Extracellular vesicles (EVs)
Natural products
Nanoparticles
Delivery
Therapeutics. Pharmacology
RM1-950
Chaoxiang Chen
Jialin Wang
Mengdi Sun
Jian Li
Hui-Min David Wang
Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery
description Phytochemicals are plant-derived bioactive compounds, which have been widely used for therapeutic purposes. Due to the poor water-solubility, low bioavailability and non-specific targeting characteristic, diverse classes of nanocarriers are utilized for encapsulation and delivery of bio-effective agents. Cell-derived nanovesicles (CDNs), known for exosomes or extracellular vesicles (EVs), are biological nanoparticles with multiple functions. Compared to the artificial counterpart, CDNs hold great potential in drug delivery given the higher stability, superior biocompatibility and the lager capability of encapsulating bioactive molecules. Here, we provide a bench-to-bedside review of CDNs-based nanoplatform, including the bio-origin, preparation, characterization and functionalization. Beyond that, the focus is laid on the therapeutic effect of CDNs-mediated drug delivery for natural products. The state-of-art development as well as some pre-clinical applications of using CDNs for disease treatment is also summarized. It is highly expected that the continuing development of CDNs-based delivery systems will further promote the clinical utilization and translation of phyto-nanomedicines.
format article
author Chaoxiang Chen
Jialin Wang
Mengdi Sun
Jian Li
Hui-Min David Wang
author_facet Chaoxiang Chen
Jialin Wang
Mengdi Sun
Jian Li
Hui-Min David Wang
author_sort Chaoxiang Chen
title Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery
title_short Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery
title_full Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery
title_fullStr Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery
title_full_unstemmed Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery
title_sort toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (cdns) for natural product delivery
publisher Elsevier
publishDate 2022
url https://doaj.org/article/578434f27eb14ee59a138eb6fea5d128
work_keys_str_mv AT chaoxiangchen towardthenextgenerationphytonanomedicinescellderivednanovesiclescdnsfornaturalproductdelivery
AT jialinwang towardthenextgenerationphytonanomedicinescellderivednanovesiclescdnsfornaturalproductdelivery
AT mengdisun towardthenextgenerationphytonanomedicinescellderivednanovesiclescdnsfornaturalproductdelivery
AT jianli towardthenextgenerationphytonanomedicinescellderivednanovesiclescdnsfornaturalproductdelivery
AT huimindavidwang towardthenextgenerationphytonanomedicinescellderivednanovesiclescdnsfornaturalproductdelivery
_version_ 1718429957578817536